N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy

Overview of attention for article published in eLife, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,277 followers.

.@Rockland_Inc, https://t.co/GsFCGBMW8z was used by the authors of the eLife paper "N-terminal domain on dystroglycan enables LARGE1 t…": https://t.co/g3Khm6R2s8 (https://t.co/XvDt42rLHx). We appreciate the author's support of reproducibility. #methodsmat…

N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy https://t.co/6djxr2WC61

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.